Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia

NCT00838240 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

114

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: clofarabine
DRUG: cytarabine
DRUG: idarubicin

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]